Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidehiro Yamada

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
The Journal of Rheumatology|March 3, 2010
Clinical activity after 12 weeks of treatment with nonbiologics in early rheumatoid arthritis may predict articular destruction 2 years laterYoichi Ichikawa, Terunobu Saito, Hisasi Yamanaka, et al.
Plos One|May 12, 2016
Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control StudyAya Kawasaki, Narumi Hasebe, Misaki Hidaka, et al.
The Journal of Rheumatology|February 9, 2018
Risk Factors for Relapse of Antineutrophil Cytoplasmic Antibody-associated Vasculitis in Japan: A Nationwide, Prospective Cohort StudyAkinori Hara, Takashi Wada, Ken-Ei Sada, et al.
Modern Rheumatology|July 8, 2025
Vaccine-related environments and patient preferences in Japanese patients with autoimmune rheumatic diseasesKenji Oku, Hidehiro Yamada, Tatsuyoshi Ikenoue, et al.
Arthritis Research & Therapy|April 20, 2012
Autoantibodies to transcription intermediary factor TIF1β associated with dermatomyositisMinoru Satoh, Jason Y F Chan, Steven J Ross, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 17, 2016
Efficacy and Safety of a Novel Endothelin Receptor Antagonist, Macitentan, in Japanese Patients With Pulmonary Arterial HypertensionNobuhiro Tahara, Hiroaki Dobashi, Keiichi Fukuda, et al.
Current Medical Research and Opinion|April 17, 2020
Long-term treatment of pulmonary arterial hypertension with macitentan in Japanese patientsNobuhiro Tahara, Hiroaki Dobashi, Keiichi Fukuda, et al.
Journal of Human Genetics|November 24, 2017
Association of ETS1 polymorphism with granulomatosis with polyangiitis and proteinase 3-anti-neutrophil cytoplasmic antibody positive vasculitis in a Japanese populationAya Kawasaki, Keita Yamashita, Fumio Hirano, et al.
Modern Rheumatology|September 8, 2015
Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52Yoshioki Yamasaki, Minoru Satoh, Machiko Mizushima, et al.
Modern Rheumatology|September 20, 2011
Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV studyShoichi Ozaki, Tatsuya Atsumi, Taichi Hayashi, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Rheumatology|March 3, 2010
Clinical activity after 12 weeks of treatment with nonbiologics in early rheumatoid arthritis may predict articular destruction 2 years laterYoichi Ichikawa, Terunobu Saito, Hisasi Yamanaka, et al.
Plos One|May 12, 2016
Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control StudyAya Kawasaki, Narumi Hasebe, Misaki Hidaka, et al.
The Journal of Rheumatology|February 9, 2018
Risk Factors for Relapse of Antineutrophil Cytoplasmic Antibody-associated Vasculitis in Japan: A Nationwide, Prospective Cohort StudyAkinori Hara, Takashi Wada, Ken-Ei Sada, et al.
Modern Rheumatology|July 8, 2025
Vaccine-related environments and patient preferences in Japanese patients with autoimmune rheumatic diseasesKenji Oku, Hidehiro Yamada, Tatsuyoshi Ikenoue, et al.
Arthritis Research & Therapy|April 20, 2012
Autoantibodies to transcription intermediary factor TIF1β associated with dermatomyositisMinoru Satoh, Jason Y F Chan, Steven J Ross, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 17, 2016
Efficacy and Safety of a Novel Endothelin Receptor Antagonist, Macitentan, in Japanese Patients With Pulmonary Arterial HypertensionNobuhiro Tahara, Hiroaki Dobashi, Keiichi Fukuda, et al.
Current Medical Research and Opinion|April 17, 2020
Long-term treatment of pulmonary arterial hypertension with macitentan in Japanese patientsNobuhiro Tahara, Hiroaki Dobashi, Keiichi Fukuda, et al.
Journal of Human Genetics|November 24, 2017
Association of ETS1 polymorphism with granulomatosis with polyangiitis and proteinase 3-anti-neutrophil cytoplasmic antibody positive vasculitis in a Japanese populationAya Kawasaki, Keita Yamashita, Fumio Hirano, et al.
Modern Rheumatology|September 8, 2015
Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52Yoshioki Yamasaki, Minoru Satoh, Machiko Mizushima, et al.
Modern Rheumatology|September 20, 2011
Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV studyShoichi Ozaki, Tatsuya Atsumi, Taichi Hayashi, et al.
Pageof 7